Shan Tang1, Andrew S Griffin, Julian A Waksal, C Douglas Phillips, Carl E Johnson, Joseph P Comunale, Sasan Karimi, Tiffany L Powell, Philip E Stieg, Philip H Gutin, Kevin D Brown, Matthew Sheehan, Samuel H Selesnick. 1. *Department of Otolaryngology-Head and Neck Surgery, Weill Cornell Medical College, New York, New York; †Department of Medicine, Weill Cornell Medical College, New York, New York; ‡Tufts University School of Medicine, Boston, Massachusetts; §Department of Radiology, Weill Cornell Medical College, New York, New York; ∥Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York; ¶Department of Neurosurgery, George Washington University School of Medicine, Washington DC; #Department of Neurological Surgery, Weill Cornell Medical College, New York, New York; **Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, New York; ††Weill Cornell Medical College, New York, New York; ‡‡Department of Otolaryngology-Head and Neck Surgery, Weill Cornell Medical College, New York, New York; and §§Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
Abstract
OBJECTIVES: To compare different methods of measuring tumor growth after resection of vestibular schwannoma and to identify predictors of growth. STUDY DESIGN: Retrospective case review. SETTING: Tertiary referral center, inpatient surgery with ambulatory follow-up. PATIENTS: All patients who underwent vestibular schwannoma resection by the senior author from September 1991 to April 2012 and had two or more postoperative MRI scans. INTERVENTIONS: Vestibular schwannoma resection. Measurement of tumor size and enhancement pattern on postoperative magnetic resonance imaging scans. MAIN OUTCOME MEASURES: Tumor size as measured in one (linear), two (planar), and three (volumetric) dimensions using standard radiology workstation tools versus time elapsed since surgical resection. RESULTS: Eighty-eight patients were included with mean follow-up of 3.9 years. Linear measurement of tumor size was found to have modest correlation with planar and volumetric measurements. Excellent correlation was found between the planar and volumetric methods. Nodular enhancement increased risk for tumor growth (OR 6.25, p = 0.03 on planar analysis). If there was growth, tumors with nodular enhancement typically showed increase in size beginning 2 years postoperatively, whereas those with linear or no enhancement were typically stable in size through 5 years. Younger age and larger preoperative tumor size were also risk factors for growth (OR 0.9/p = 0.01 and OR 1.09/p = 0.02). CONCLUSION: Simple planar measurement is an efficient method that correlates well with the more time-consuming volumetric method. The major risk factor for tumor growth is nodular enhancement on a baseline scan, a finding that warrants annual MRI beginning 2 years postoperatively. Younger age and larger preoperative size minimally increased risk of growth.
OBJECTIVES: To compare different methods of measuring tumor growth after resection of vestibular schwannoma and to identify predictors of growth. STUDY DESIGN: Retrospective case review. SETTING: Tertiary referral center, inpatient surgery with ambulatory follow-up. PATIENTS: All patients who underwent vestibular schwannoma resection by the senior author from September 1991 to April 2012 and had two or more postoperative MRI scans. INTERVENTIONS:Vestibular schwannoma resection. Measurement of tumor size and enhancement pattern on postoperative magnetic resonance imaging scans. MAIN OUTCOME MEASURES: Tumor size as measured in one (linear), two (planar), and three (volumetric) dimensions using standard radiology workstation tools versus time elapsed since surgical resection. RESULTS: Eighty-eight patients were included with mean follow-up of 3.9 years. Linear measurement of tumor size was found to have modest correlation with planar and volumetric measurements. Excellent correlation was found between the planar and volumetric methods. Nodular enhancement increased risk for tumor growth (OR 6.25, p = 0.03 on planar analysis). If there was growth, tumors with nodular enhancement typically showed increase in size beginning 2 years postoperatively, whereas those with linear or no enhancement were typically stable in size through 5 years. Younger age and larger preoperative tumor size were also risk factors for growth (OR 0.9/p = 0.01 and OR 1.09/p = 0.02). CONCLUSION: Simple planar measurement is an efficient method that correlates well with the more time-consuming volumetric method. The major risk factor for tumor growth is nodular enhancement on a baseline scan, a finding that warrants annual MRI beginning 2 years postoperatively. Younger age and larger preoperative size minimally increased risk of growth.
Authors: Stuart Currie; David Saunders; Jeremy Macmullen-Price; Sanjay Verma; Philip Ayres; Caroline Tait; Ceryl Harwood; Andrew Scarsbrook; Ian J Craven Journal: Br J Radiol Date: 2019-01-23 Impact factor: 3.039
Authors: Kevin A Peng; Brian S Chen; Mark B Lorenz; Gregory P Lekovic; Marc S Schwartz; William H Slattery; Eric P Wilkinson Journal: J Neurol Surg B Skull Base Date: 2018-04-09
Authors: Romain Kania; Benjamin Vérillaud; Domitille Camous; Charlotte Hautefort; Thomas Somers; Jérôme Waterval; Sébastien Froelich; Philippe Herman Journal: J Int Adv Otol Date: 2018-04 Impact factor: 1.017
Authors: Samuel MacKeith; Tilak Das; Martin Graves; Andrew Patterson; Neil Donnelly; Richard Mannion; Patrick Axon; James Tysome Journal: Eur Arch Otorhinolaryngol Date: 2018-01-15 Impact factor: 2.503